April 8, 2024
 
 

Small Stocks, Big Money™

Weekly Newsletter
REDCHIP.COM
 
 
LOBO EV Forges Strategic Collaboration with CSM2017 to Expand E-Bicycle Business in Serbia
 
LOBO EV Technologies Ltd. (Nasdaq: LOBO), an innovative electric vehicle manufacturer and seller, announced its new strategic collaboration with Serbian distributor CSM2017 Doo, marking a milestone in its expansion into the burgeoning electric vehicle market in Eastern Europe. With a growing demand for sustainable transportation options, the region presents a ripe opportunity for LOBO EV’s innovative product lineup, starting with the CSM-01 e-bicycle.
 
 
 
 
 
 
 
 
Genius Group Launches AI Avatar Toolkit for Global Faculty to build their own AI Tutors
 
Genius Group (NYSE American: GNS), a leading AI-powered education group, announced the launch of its artificial intelligence (“AI”) Avatar Toolkit on its Edtech platform, GeniusU, enabling its global faculty of 15,000 education partners to build their own AI tutors and learning assistants to provide personalized, guided learning to their students.
 
 
 
 
 
 
 
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
 
Zomedica (NYSE American: ZOM), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, reported consolidated financial results for the fourth quarter and year-ended December 31, 2023. "The fourth quarter capped off another record quarter and year for Zomedica. On the strength of our highest revenue quarter ever, we grew full year revenue by over 33%, due to early adoption of newly launched products in our Diagnostics segment, and continued strength in our Therapeutic Devices segment," commented Zomedica Chief Executive Officer, Larry Heaton.
 
 
 
 
 
 
 
 
 
 
60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
 
60 Degrees Pharmaceuticals (Nasdaq: SXTP), a pharmaceutical company focused on developing new medicines for infectious diseases, announced that the Company will sponsor a pilot study of tafenoquine, the active molecule in its U.S. Food and Drug Administration (FDA)-approved human malaria prevention medication, ARAKODA®, for the treatment of babesiosis in dogs. The study will support a broader effort now being led by 60 Degrees Pharmaceuticals to evaluate tafenoquine for various babesiosis indications.
 
 
 
 
 
 
 
ASP Isotopes Inc. Enters Into Purchase Agreement With a Leading Semiconductor Company for the Supply of Highly Enriched Electronic Gases
 
ASP Isotopes (Nasdaq: ASPI), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced that it has entered into a purchase agreement with an industry leader in the design and manufacturing of semiconductors. Under the terms of the agreement, ASP Isotopes expects to supply highly enriched silicon-28 to the customer for use in next-generation semiconductors. The product is expected to be supplied from the Company’s South African production facility and shipped to the customer in the USA during 2024.
 
 
 
 
 
 
 
Small Stocks, Big Money™ Podcast
 
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
amazon music apple music spotify music
 
 
 
 
 
 
Upcoming Events
 
 
9
 
 
Apr 2024
 
NASDAQ: GENE - Genetic Technologies Limited
4:15pm Eastern
 
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health.
 
 
 
 
 
 
 
10
 
 
Apr 2024
 
NASDAQ: BIVI - BioVie Inc.
4:15pm Eastern
 
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease.
 
 
 
 
 
 
 
11
 
 
Apr 2024
 
OTC: CBDW - 1606 Corp.
4:15pm Eastern
 
1606 Corp. (OTC: CBDW) stands at the forefront of technological innovation in the online CBD industry. With a clear mission to revolutionize customer service in the digital marketplace, 1606 Corp. leverages state-of-the-art artificial intelligence (AI) solutions to address the significant challenges faced by consumers in the online CBD sector.
 
 
 
 
 
 
 
Archived Events
 
 
4
 
 
Apr 2024
 
NASDAQ: BTCY - Biotricity
4:15pm Eastern
 
Biotricity is a pioneering medical technology company delivering a full suite of remote diagnostic and remote patient monitoring hardware solutions which integrate with powerful and proprietary software solutions to deliver state-of-the-art cardiac care to patients.
 
 
 
 
 
 
Quote of the Week
 
"You get rich buying stocks. You stay rich buying bonds. It's as simple as that. If you want to grow your money over time, stocks are the only game in town. Don't waste your time on gold or options or futures or hog bellies or corporate bonds or certificates of deposit or pass-book savings accounts or money-market accounts or rare coins or stamps or Picassos or baseball cards or ostrich farms or collectibles. Buy stocks."
— Charles B. Carlson, CFA, Eight Steps to Seven Figures
 
 
RedChip TV
 
 
 
 
RedChip TV Highlights LOBO EV (NASDAQ: LOBO) & BIOTRICITY (NASDAQ: BTCY) This Week
 
 
 
 
 
 
 
Biotricity: Revolutionizing Cardiac Care with Remote Monitoring Technology
 
 
 
 
 
 
 
Order "Small Stocks, Big Money™ Today!
 
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
 
 
 
 
 
 
 
Lesson of the Week
 
The tenets of value investing still hold true today.
 
 
 
 
 
 
 
MidSouth Week in Review
 
Gold hit a new high at $2,346. Major indexes fell sharply Thursday after Federal Reserve officials suggested interest rate cuts may not be imminent.